Literature DB >> 20926815

A novel method for the induction of experimental glaucoma using magnetic microspheres.

Paulina A Samsel1, Lilian Kisiswa, Jonathan T Erichsen, Stephen D Cross, James E Morgan.   

Abstract

PURPOSE: The development of a method for the sustained elevation of intraocular pressure in experimental glaucoma based on the anterior chamber injection of paramagnetic microbeads.
METHODS: Unilateral glaucoma was induced in adult male Norwegian Brown rats by the injection of paramagnetic polystyrene microspheres. A handheld 0.45 Tesla magnet was used to draw the beads into the iridocorneal angle to impede aqueous drainage via the trabecular meshwork.
RESULTS: Elevated intraocular pressures (IOPs) were induced in 61 rats, resulting in a mean elevation of 5.8 mm Hg ± 1.0 (SEM) relative to the contralateral control eye. The mean duration of sustained IOP elevation (defined as >5 mm Hg relative to the control eye for at least 7 consecutive days) after a single injection was 12.8 days ± 0.9 (SEM, maximum duration 27 days). In all eyes, the visual axis remained clear from the time of injection, with minimal inflammation after injection. Retinal ganglion cell loss was determined in 21 animals (mean integral IOP, 194.5 mm Hg days ± 87.5 [SEM]) as 36.4% ± 2.4 (SEM) compared with the contralateral, untreated eye.
CONCLUSIONS: The use of paramagnetic microbeads for the occlusion of the iridocorneal angle produces a sustained elevation of IOP with fewer injections and avoids the risk of visual axis occlusion. It represents a simple and effective method for the induction of experimental glaucoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20926815     DOI: 10.1167/iovs.09-3921

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  53 in total

Review 1.  Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure.

Authors:  John C Morrison; William O Cepurna; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

2.  Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma.

Authors:  Kevin C Chan; Yu Yu; Shuk Han Ng; Heather K Mak; Yolanda W Y Yip; Yolandi van der Merwe; Tianmin Ren; Jasmine S Y Yung; Sayantan Biswas; Xu Cao; Ying Chau; Christopher K S Leung
Journal:  Acta Biomater       Date:  2019-06-06       Impact factor: 8.947

3.  Lack of immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma.

Authors:  Qiong J Ding; Amy C Cook; Alina V Dumitrescu; Markus H Kuehn
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-19       Impact factor: 4.799

Review 4.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

5.  Prolonged elevation of intraocular pressure results in retinal ganglion cell loss and abnormal retinal function in mice.

Authors:  A Kareem Khan; Dennis Y Tse; Meike E van der Heijden; Priya Shah; Derek M Nusbaum; Zhuo Yang; Samuel M Wu; Benjamin J Frankfort
Journal:  Exp Eye Res       Date:  2014-11-18       Impact factor: 3.467

6.  Development of a model of elevated intraocular pressure in rats by gene transfer of bone morphogenetic protein 2.

Authors:  Lakisha K Buie; Md Zahidul Karim; Matthew H Smith; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

7.  Effect of general anesthetics on IOP in elevated IOP mouse model.

Authors:  Chun Ding; Ping Wang; Ning Tian
Journal:  Exp Eye Res       Date:  2011-03-30       Impact factor: 3.467

8.  Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice.

Authors:  Derek M Nusbaum; Samuel M Wu; Benjamin J Frankfort
Journal:  Exp Eye Res       Date:  2015-04-23       Impact factor: 3.467

9.  Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma.

Authors:  Benjamin J Frankfort; A Kareem Khan; Dennis Y Tse; Inyoung Chung; Ji-Jie Pang; Zhuo Yang; Ronald L Gross; Samuel M Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

Review 10.  Solving the lost in translation problem: improving the effectiveness of translational research.

Authors:  Ceren Ergorul; Leonard A Levin
Journal:  Curr Opin Pharmacol       Date:  2012-09-11       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.